Caricamento...
Duration of High-Dose Aspirin Therapy does not Affect Long-Term Coronary Artery Outcomes in Kawasaki Disease
BACKGROUND: High-dose aspirin (HDA) is used with intravenous immunoglobulin (IVIg) in Kawasaki Disease (KD). Practice regarding HDA varies, and it is unclear whether HDA duration affects long-term course. METHODS: We retrospectively studied KD patients at our hospital over 10 years. Patients were ca...
Salvato in:
| Pubblicato in: | Pediatr Res |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6019159/ https://ncbi.nlm.nih.gov/pubmed/29554081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pr.2018.44 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|